NLRP3 and COVID-19: In support of this, specific inhibition of the NLRP3 inflammasome by MCC950 alleviated excessive lung inflammation and thus COVID-19-like pathology in human Angiotensin-converting enzyme 2 (ACE2) transgenic mice infected with SARS-CoV-2 (16).